Raffaele Baffa's most recent trade in Alaunos Therapeutics Inc was a trade of 80,645 Common Stock done . Disclosure was reported to the exchange on May 17, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alaunos Therapeutics Inc | Raffaele Baffa | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 80,645 | 280,645 (0%) | 0% | 0 | Common Stock |